Literature DB >> 1794366

Development of resistance to quinolones in five patients with campylobacteriosis treated with norfloxacin or ciprofloxacin.

H Adler-Mosca1, J Lüthy-Hottenstein, G Martinetti Lucchini, A Burnens, M Altwegg.   

Abstract

Development of resistance to nalidixic acid, norfloxacin and ciprofloxacin was observed in five patients with Campylobacter jejuni or Campylobacter coli infection. From all these patients nalidixic acid- and quinolone-susceptible strains were isolated initially, whereas after therapy with norfloxacin or ciprofloxacin strains resistant to these antibiotics were found. Campylobacter strains from the same patient always belonged to the same species and, with the exception of one case, showed identical rRNA gene restriction (rDNA) patterns. This indicates that double-infection with a susceptible and a resistant strain was not responsible for the phenomenon but rather that the infecting strain rapidly developed resistance following treatment.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1794366     DOI: 10.1007/BF02005451

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

1.  Fluoroquinolone resistance in Campylobacter spp isolated from human stools and poultry products.

Authors:  H P Endtz; R P Mouton; T van der Reyden; G J Ruijs; M Biever; B van Klingeren
Journal:  Lancet       Date:  1990-03-31       Impact factor: 79.321

2.  Empiric antimicrobial therapy of domestically acquired acute diarrhea in urban adults.

Authors:  L J Goodman; G M Trenholme; R L Kaplan; J Segreti; D Hines; R Petrak; J A Nelson; K W Mayer; W Landau; G W Parkhurst
Journal:  Arch Intern Med       Date:  1990-03

3.  Problems in identification of Campylobacter jejuni associated with acquisition of resistance to nalidixic acid.

Authors:  M Altwegg; A Burnens; J Zollinger-Iten; J L Penner
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

4.  Diarrhea and Campylobacter infections in patients infected with the human immunodeficiency virus.

Authors:  E Bernard; P M Roger; D Carles; V Bonaldi; J P Fournier; P Dellamonica
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

5.  Susceptibility of Campylobacter fetus subsp. jejuni to twenty-nine antimicrobial agents.

Authors:  R Vanhoof; M P Vanderlinden; R Dierickx; S Lauwers; E Yourassowsky; J P Butzler
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

6.  rRNA gene restriction patterns and plasmid analysis as a tool for typing Salmonella enteritidis.

Authors:  G Martinetti; M Altwegg
Journal:  Res Microbiol       Date:  1990 Nov-Dec       Impact factor: 3.992

7.  In vitro susceptibility of Campylobacter jejuni to rokitamycin.

Authors:  Y Miyake; M Okada; M Sasaki; N Nagasaka; H Suginaka
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

8.  In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Austria to erythromycin and ciprofloxacin.

Authors:  A M Hirschl; D Wolf; J Berger; M L Rotter
Journal:  Zentralbl Bakteriol       Date:  1990-04

9.  Susceptibility of clinical isolates of Campylobacter jejuni to twenty-five antimicrobial agents.

Authors:  L A Lariviere; C L Gaudreau; F F Turgeon
Journal:  J Antimicrob Chemother       Date:  1986-12       Impact factor: 5.790

10.  A new selective medium for the isolation of Campylobacter jejuni from human faeces.

Authors:  H Goossens; M De Boeck; J P Butzler
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

View more
  18 in total

1.  Susceptibilities of Campylobacter jejuni isolates from Germany to ciprofloxacin, moxifloxacin, erythromycin, clindamycin, and tetracycline.

Authors:  Jutta Wagner; Miriam Jabbusch; Martin Eisenblätter; Helmut Hahn; Constanze Wendt; Ralf Ignatius
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

2.  Increased resistance of enteropathogens to fluoroquinolones in Barcelona, Spain.

Authors:  F Navarro; E Miró; C Izquierdo; B Mirelis; G Prats
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-08       Impact factor: 3.267

3.  Double-blind comparison of ofloxacin for 3 days and placebo in acute bacterial enteritis.

Authors:  A Halstensen; P Voltersvik; G Gossius; A Digranes; L E Peterson; T Rolstad; C O Solberg
Journal:  Drugs       Date:  1995       Impact factor: 9.546

4.  Development of resistance to macrolide antibiotics in an AIDS patient treated with clarithromycin for Campylobacter jejuni diarrhea.

Authors:  G Funke; R Baumann; J L Penner; M Altwegg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-07       Impact factor: 3.267

5.  Prevalence, molecular characterization and antimicrobial resistance of thermophilic campylobacter isolates from cattle, hens, broilers and broiler meat in south-eastern Italy.

Authors:  A Parisi; S G Lanzilotta; N Addante; G Normanno; G Di Modugno; A Dambrosio; C O Montagna
Journal:  Vet Res Commun       Date:  2006-12-15       Impact factor: 2.459

6.  Etiological agents of infectious diarrhea: implications for requests for microbial culture.

Authors:  P Rohner; D Pittet; B Pepey; T Nije-Kinge; R Auckenthaler
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

7.  Rapid emergence of quinolone resistance in cirrhotic patients treated with norfloxacin to prevent spontaneous bacterial peritonitis.

Authors:  C Dupeyron; N Mangeney; L Sedrati; B Campillo; P Fouet; G Leluan
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

8.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

9.  In vitro activity of azithromycin against bacterial enteric pathogens.

Authors:  M E Gordillo; K V Singh; B E Murray
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

Review 10.  Bacterial resistance to fluoroquinolones: lessons to be learned.

Authors:  P Ball
Journal:  Infection       Date:  1994       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.